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1. Introduction 
Total hip arthroplasty (THA) is one of the most successful orthopaedic procedures and has 
relieved pain and improved hip function in millions of patients worldwide. Despite the 
success of modern prosthetic designs and bearing surfaces, around 10% of THA prostheses 
still fail within 10 years1. Improvements in surgical technique and prosthesis design have 
decreased the incidence of deep sepsis, dislocation and fracture, however aseptic loosening, 
the clinical end point of osteolysis, remains the most frequent complication and in the UK 
accounts for 63% of all revision surgery (Table 1)2. Prosthesis loosening results in pain and 
disability, requiring revision surgery. Revision THA is associated with a 3 to 8-fold greater 
in-hospital mortality, poorer functional outcome, longer hospital stay, and higher cost than 
primary surgery1,3-5.  
The problem of osteolysis has been recognized in Judet’s acrylic hemiarthroplasty 
introduced in the 1940s. Prosthesis loosening complicating THA in the 1950’s and 1960’s 
was poorly understood and attributed to unconfirmed sepsis6 and prosthesis motion7. In the 
1980’s loosening was thought to be the result of “cement disease”8, arising due to a foreign 
body reaction to methyl methacrylate. When the development of cementless prostheses 
 
National Joint Registry hip Annual Report Data 2009 
 Number % 
Total procedures 72,432  
Primary procedures 65,229 90% 
Revision procedures 7,203 10% 
Indication for revision   
Aseptic Loosening 3,524 49% 
Osteolysis 999 14% 
Pain 2,035 29% 
Infection 1,020 14% 
Dislocation/ subluxation 1,141 16% 
Periprosthetic fracture 618 9% 
Table 1. Summary of hip surgery data from 7th Annual Report National Joint Registry for 
England and Wales2 
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failed to eliminate this problem, wear at the bearing couple was subsequently identified as 
the main source of particulate debris giving rise to osteolysis.  
Advances in prosthesis materials, design and surgical technique have improved the wear 
performance of prostheses, which will decrease the future incidence of osteolysis. However, 
an ageing population combined with younger more active patients now undergoing joint 
arthroplasty suggests that osteolysis and resulting prosthesis loosening will continue to be 
the major complication of THA. 
2. Pathophysiology of osteolysis 
The term aseptic loosening describes mechanical failure of the prosthesis-host interface, and 
arises primarily as the end result of focal periprosthetic inflammatory bone loss occurring at 
this interface. This pro-inflammatory microenvironment is driven by particulate wear debris, 
which is generated primarily at the articular bearing surface and at other non-articular 
prosthesis or cement surfaces9. Willert first proposed the involvement of prosthetic debris in 
the development of oesteolysis. He identified a resultant foreign body reaction and granuloma 
formation which included macrophages and multinucleated giant cells10. This foreign body 
reaction has subsequently been reproduced in animal models11. Once particulate wear debris 
has been dispersed into the joint fluid it may initiate a foreign body reaction at contact surfaces 
with the host tissues. Schmalzried coined the term “effective joint space” to describe all areas 
where open communication with the joint pseudo-capsule may allow circulation of the joint 
fluid and particulate debris12. The effective joint space is thus dynamic and may advance along 
a tissue plane as osteolysis progresses. Variations in hydrostatic pressure within the joint space 
during activity may contribute to this circulation12. 
As well as its role in the migration of wear particles, hydrostatic fluid pressure changes 
within the joint have been implicated as an osteolytic stimulus. Aspenberg showed in an 
animal model that fluid pressure alone can lead to osteolysis13. Skoglund also showed that 
the osteolytic effect of fluid pressure on the bone was greater than that of particles14. 
However, it remains unclear what contribution this potential mechanism makes to the 
development of osteolysis clinically. Early migration of the femoral component may predict 
early and mid-term prosthesis failure. It has been suggested that this migration may lead to 
instability resulting in locally high fluid pressures which may, in turn, lead to osteolysis15. 
However, it is also likely that the predictive value of early migration measurements is due to 
the identification of failures of initial prosthesis fixation, resulting in loosening due to 
technical failure.  
3. The biology of osteolysis 
The process of aseptic loosening is characteristically accompanied with the development of a 
fibrous membrane at the bone-cement interface. Histological analysis of this membrane has 
shown a synovial-like fibrovascular tissue containing cells including macrophages, 
fibroblasts and foreign body giant cells9,16. The predominant cell types driving osteolysis, 
the macrophage and fibroblast, signal through various pro-inflammatory cytokines 
(including the interleukins, TNF alpha, and vascular endothelial growth factor VEGF) 
following either phagocytosis of the particles or through surface contact17.  
The biological process through which wear particles induce this inflammatory response is 
still not fully understood. It has become clear that the innate immune system is involved in 
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the initiation of the biological response. The innate immune system is the body’s first 
defense against foreign pathogens. Its ability to recognize and eliminate pathogens relies on 
pattern recognition receptors (PRR). PRRs are expressed by several cells in the monocyte cell 
lineage and include toll-like receptors (TLR) and the NOD-like receptors (NLR). These 
subfamilies evoke an inflammatory response either through the activation of transcription 
factors or through the formation of inflammasomes (Figure 1). Inflammasomes are large 
cytoplasmic complexes that activate inflammatory caspases required for the catalysis of pro-
IL-1β and pro-IL-18 into their active forms18. Disorders of inflammasome signaling are 
associated with a number of auto-inflammatory conditions.  
 
 
Fig. 1. Summary of pattern recognition receptors and their effector pathways. NALP = 
NACHT, LRR and PYD domain-containing proteins, IPAF = Ice protease activating factor, 
NAIP = neuronal apoptosis inhibitory protein, NOD = nucleotide-binding oligomerization 
domain proteins, CIITA = Major histocompatibility complex class-2 transactivator 
Caicedo et al found that metal implant debris stimulated an inflammatory response in 
macrophages through inflammasome signaling (Figure 2)19. Maitra found that UHMWPE 
wear particles are phagocytosed causing intracellular activation of NACHT, LRR and PYD 
domains-containing protein 3 (NLRP3) leading to inflammasome formation. In addition 
alkane polymers generated by UHMWPE activate TLRs through cell surface contact. This 
leads to the activation of transcription factors including NF-KB resulting in cytokine 
release20. St Pierre et al showed in a mouse model that titanium particles also induce an 
inflammatory response through the activation of the NLRP3 inflammasome21. 
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Fig. 2. Toll-like receptor and inflammasome signaling in response to wear debris 
The released pro-inflammatory cytokines, in turn, modulate the activation of other cell types 
in the periprosthetic environment, including osteoblasts. Osteoblasts closely interact with 
osteoclasts in coupled bone remodeling, regulating bone resorption through the activation 
of osteoclasts22. Activated osteoblasts stimulate the monocyte / macrophage cell lineage 
through activation of receptor activator of nuclear factor κ B (RANK) by its ligand (RANKL) 
and macrophage colony stimulating factor (M-CSF). Together these induce expression of 
genes required for the development and maturation of polykaryon osteoclasts and 
activation of their function of bone resorption23. This upregulation of periprosthetic bone 
resorption results in failure of the integrity of the prosthesis-host construct and loosening of 
the prosthesis. Activated macrophages also produce matrix metalloproteinases (MMPs) that 
directly degrade demineralized collagen matrix.  
Fibroblasts are the most frequent cell type found in the loosening membrane, and also 
play a role in the pathogenesis of osteolysis. They produce the fibrous collagenous matrix 
which surrounds the prosthesis and in addition, secrete RANKL and IL-6 which are both 
osteoclastogenic and stimulate the formation of multinucleated giant cells24,25. In addition 
to upregulation of the osteoclastic response, particulate debris suppresses differentiation 
of mesenchymal stem cells (MSC) into mature functioning osteoblasts and reduces 
synthetic activity of mature osteoblasts further shifting turnover balance in favor of net 
bone loss26. 
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Fig. 3. Summary of biological response to wear debris. Recruitment and activation of 
osteoclasts may occur directly through the production of RANKL by fibroblasts, or 
indirectly through the production of pro-inflammatory cytokines that stimulate the 
production of RANKL by the osteoblast. TNF may stimulate osteoclast differentiation and 
activation through both routes. 
other cell types may also be involved in the inflammatory response to wear particulate 
debris. These include lymphocytes and mast cells. The presence of lymphocytes suggests 
involvement of the adaptive immune system. It is suggested that particulate debris may 
undergo opsonisation which allows them to be targeted by B and T lymphocytes. 
Degranulated mast cells have been found in the periprosthetic tissue surrounding loose 
prostheses confirming their activation in the process of osteolysis27 
Although aseptic loosening, by definition, occurs in the absence of bacterial infection, recent 
evidence suggests that bacterial endotoxin may contribute. Gram-positive and gram-
negative bacteria produce (as constituent components of their cell walls or as toxins) a 
number of molecules including endotoxins and peptidoglycans, collectively termed 
pathogen associated molecular patterns (PAMPs) that act as ligands for PRRs. The presence 
of PAMPs has been confirmed in the periprosthetic tissue of patients undergoing revision 
surgery for aseptic loosening28. Using RNA gene sequencing, the presence of bacteria in the 
periprosthetic biofilm surrounding loose prostheses has also now been confirmed29. It has 
been shown both in vitro and in animal models that PAMPs adherent to particulate debris 
activate PRRs on macrophages, increasing the biological activity of wear particles30. 
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4. Risk factors for osteolysis 
Although the final pathway to the development of aseptic loosening is process of 
mechanical failure of the construct driven by inflammatory-mediated bone loss, multiple 
factors mediate an individual’s susceptibility to this process. These may broadly be divided 
into patient, surgical, and prosthesis-related factors (Figure 4). Although not an exhaustive 
list, some of these proposed factors that have been identified and validated will be 
discussed. 
 
 
 
Fig. 4. Summary of risk factors that influence the development of aseptic loosening 
5. Patient risk factors 
5.1 Preoperative diagnosis 
The most common indication for THA is idiopathic osteoarthritis. Within this diagnosis 
group, those with an atrophic pattern of bone response to osteoarthritis are at increased risk 
of acetabular prosthesis loosening31. Proximal femoral bone geometry may also affect 
prosthesis survival, with large non-tapering femoral canal shape (stove-pipe) being 
associated with an increased risk of aseptic loosening31. 
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Higher rates of prosthesis loosening also occur in patients who have undergone arthroplasty 
for post-traumatic arthritis and osteonecrosis when compared with primary osteoarthritis. 
However, it is thought that this finding may relate to higher activity levels and increased 
bearing surface wear, rather than being a function of the pre-operative diagnosis32,33.  
A number of preoperative diagnoses carry a possible increased risk of prosthesis failure 
through associated medication. Patients taking systemic steroids have been found to have a 
higher risk of reoperation34. Non-steroidal anti-inflammatory drugs (NSAIDs) have been 
implicated in impaired bone healing, and patients taking NSAIDs have higher reoperation 
rates, although NSAID use may be acting as a marker of a painful prosthesis rather than 
contributing directly to prosthesis failure34. 
Poorer prosthesis survival might be expected in patients with inflammatory arthropathy 
due to its inflammatory pathogenesis and the historic frequent use of corticosteroids in 
its treatment (that are associated with loss of bone mass through osteoblast suppression). 
However, Furnes et al, in a large arthroplasty registry-based study, found no difference 
in THA survival between patients with rheumatoid arthritis versus those with 
osteoarthritis35. Rud-Sorensen et al found that the risk of stem revision due to aseptic 
loosening was lower in rheumatoid patients versus primary osteoarthritis, whilst 
acetabular prosthesis survival was similar36. 
Furnes et al and Bordini et al have reported higher acetabular revision rates due to aseptic 
loosening in patients with a primary diagnosis of developmental dyplasia of the hip 
compared to primary osteoarthritis37,38. Rates of acetabular prosthesis failure are higher in 
younger patients and those with greater graft coverage of the cup39. The role of these 
factors is unclear, but may relate to activity levels, or mechanical factors influencing 
prosthesis support. 
5.2 Body mass index and obesity 
The Health Survey for England 2009 showed that over the last 16 years there has been 
marked increase in the proportion of the population that are obese. This proportion 
increased from 13% of men in 1993 to 22% in 2009 and from 16% of women in 1993 to 24% in 
200940. The mean BMI of a patient undergoing THA in England and Wales has increased 
over the last 5 years from 27.4 to 28.4. Likewise the percentage of patients classed as either 
obese or morbidly obese has risen from 29% in 2004 to 37%  
Historically, obesity has been deemed a relative contraindication for THA41, as the joint 
reaction force experienced at the hip is directly proportional to body weight, and thus 
obesity was considered a risk factor for prosthesis failure. Obesity is associated with a 
higher incidence of perioperative complications including cardiovascular and respiratory 
events42, venous thrombosis43, wound infection44, and dislocation45. However, despite the 
increase in joint load in these patients, no consistent increase in bearing wear or osteolysis 
has been shown across study populations46,47 and thus obesity is not a clear risk factor for 
osteolysis.  
5.3 Bearing-surface wear and activity level 
Patient activity level associates with osteolysis. It is thought this association operates 
primarily though the production of wear of the bearing surface. Flugsrud showed that 
patients who undertake intermediate to intense activity are four times more likely than the 
less-active to develop acetabular prosthesis loosening48. A recent study with five to ten year  
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Fig. 5. Continuous dose-response relationship between prosthesis bearing wear and risk of 
osteolysis. Top panel shows data from a study of 115 cases and 115 controls after Charnley 
THA with consistent increase in proportion of subjects with osteolysis with increasing wear 
rate (by quintile)57. Bottom panel shows survivorship analysis in a cohort study of 319 
hybrid THAs followed for a minimum of 10 years, and showing a similar dose-response 
relationship between osteolysis and polyethylene wear58.  
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follow up has shown that 24% of patients who have engaged in high levels of activity 
developed femoral osteolysis, and had higher revision rates49. 
Traditionally the rate of polyethylene wear has been reported as a function of time. The 
results from ex-vivo hip simulator experiments have shown that the number of hip cycles is 
proportional to the rate of wear of prosthesis surface50. In vivo, there is a great range of wear  
rates between individual as a consequence of differing activity levels51. Several validated 
assessment tools have been developed to measure activity levels in arthroplasty 
populations52, and Schmalzried et al showed that wear in patients is a function of activity53.  
There are no clear guidelines outlining what levels of activity can be undertaken 
following THA although the proportion of patients participating in athletic activity 
following THA ranges between 52 – 83%54-56. Whilst low-impact activities such as 
walking, swimming and cycling have always been recommended following THA, some 
patients participate in more high-impact and competitive sports. The increasing 
participation in athletic activity and higher post-operative expectations can partly be 
explained by the increasing numbers of younger patients undergoing THA. 42% of men 
and 31% of women who underwent THA in England and Wales in 2009 were under the 
age of 65 years2. A large number of patients over the age of 65 are also participating in 
high levels of activity49. 
Several investigators have shown a relationship between high levels of polyethylene wear 
and osteolysis/aseptic loosening, and the concept of a wear-rate ‘threshold’ (commonly 
defined as 0.1mm/year) below which osteolysis occurs very rarely, has been suggested. 
Wilkinson et al quantitated the association between wear and osteolysis and found no 
evidence to support this concept. In a case-control study of 230 hips after cemented 
Charnley THA with a metal on polyethylene bearing they showed that the risk of osteolysis 
increased with each quintile increase in wear, from very low levels of wear, below the 
suggested threshold, through to high levels57. They subsequently showed that the risk of 
osteolysis showed a similar pattern of consistently increasing risk ratio with each wear rate 
quintile in a separate cohort study of patients with 319 hybrid THAs using a metal on 
conventional polyethylene bearing (Figure 5). 
5.4 Genetic factors 
Within a given ethnic population the sequence of DNA between individuals is 99.5% 
identical. However, variability within the code does occur and gives rises to the phenotypic 
variability within the population. These variants occur at approximately every 1000 
nucleotide base pairs of the code. This variation, where it occurs in >1% of the population is 
termed a polymorphism. The most common type of variant is a single letter change in the 
DNA sequence, termed a single nucleotide polymorphism (SNP). There are thought to be 
around 10 million common SNPs in the human genome. The individual specific risk of 
common diseases is thought to be influenced by the sum of many genetic variations, each 
potentially causing small changes in biological function and consequently subtle changes in 
phenotype59. 
Patients vary in their osteolytic response to particulate wear debris. Some show little bone 
resorption in the presence of marked prosthesis wear whereas others undergo marked 
osteolysis following a small amount of prosthesis wear (Figure 6)57. Macrophage 
responsiveness to in-vitro particulate debris stimulation also varies between individual60, 
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and monocytes (PBMCs) taken from patients with a susceptibility to osteolysis exhibit 
quantitatively greater inducible cytokine responses to particulate debris in-vitro versus 
patients without this susceptibility61 . It is suggested that this inter-patient variability may 
have a genetic basis. 
 
Fig. 6. Patients exhibit variable osteolytic responses to wear debris. a) radiograph 
showing marked polyethylene wear, but no osteolytic response, b) radiograph  
showing mild wear but pronounced femoral and acetabular osteolysis with prosthesis 
loosening. 
Variation within the genes encoding inflammatory cytokines have been associated with 
osteolysis. Wilkinson et al showed an association between variability within the DNA 
encoding the tumor necrosis factor (TNF) promoter region (dbSNP rs361525) and risk of 
osteolysis following THA62. Subjects with osteolysis were approximately twice as likely to 
carry the variant DNA code as those subjects with no osteolysis. This association has been 
replicated in an independent population by Ambruzova et al63. Gordon et al have reported 
genetic variation within the genes encoding Interleukin-1 receptor antagonist (IL-1RN) and 
IL-6 is also associated with osteolysis64. Similar associations have also been identified in 
other populations65-67.  
Variation within genes that regulate bone turnover also associate with osteolysis. Gordon et 
al showed that carriage of the dbSNP rs288326 variant in the FRZB gene encoding secreted 
frizzled-related protein-3 (Frp3), a regulatory glycoprotein within the osteogenic Wnt 
signaling pathway that modulates mesenchymal stem cell differentiation of osteoblasts68, 
associated with susceptibility to osteolysis following THA69. Its carriage also associated with 
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the development of heterotopic ossification following THA. Malik et al have also shown 
associations between aseptic loosening and other candidate loci within the genes encoding 
matrix metalloproteinase 1 and the vitamin D receptor67, mannose-binding lectin70, and the 
RANK/OPG pathway71.  
Recent studies using beadchip assays have shown that many genes are differentially 
expressed in wear debris-induced cells and tissues72-74, and have highlighted our limited 
understanding of the spectrum of biological mediators involved in the pathogenesis of 
osteolysis. The identification of further risk loci is required to further understanding of the 
pathogenesis of aseptic loosening. This would potentially allow for the development of 
screening tools, and provide investigational targets for prophylaxis or treatment with the 
aim of reducing the need for revision surgery, and its associated morbidity and mortality. 
6. Prosthesis risk factors 
6.1 Prosthesis design 
Prosthesis design factors, aside from those that modulate wear, contribute to risk of 
osteolysis. Modularity allows intra-operative adjustment of bearing surfaces, prosthesis 
length and offset. However, it also creates additional interfaces within the construct at 
which generation of debris through wear may occur. Such interfaces include the trunion 
between the femoral head and stem at which corrosive wear may occur, and backside wear 
between an acetabular liner and its shell at which abrasive wear may occur, and potentially 
several other prosthetic component junctions in highly modular systems. Hydroxyapatite 
coating of the prosthesis may prevent osteolysis following injection of intra-articular 
particles by sealing the implant-bone interface from their ingression though the promotion 
of osseointegration at this interface75,76, but may also be a source of third-body wear. 
Selection of bearing diameter is also a factor. The use of larger head sizes reduces the risk of 
dislocation, but increase volumetric wear77. The need for a thinner liner to accommodate the 
larger head may also cause increased contact stresses and an increase in wear. 
6.2 Polyethylene wear 
The metal on polyethylene bearing couple remains the gold standard for THA. However, 
the manufacturing and sterilization process of polyethylene has changed over time with 
the aim of improving its wear rate characteristics. The earliest prostheses were made with 
non-cross-linked ultra-high molecular weight polyethylene (UHWPE) that was irradiated 
to render it sterile for patient use. The process of sterilization with ionizing radiation leads 
to cross-linking within the polymer. Cross-linking improves wear resistance of the 
material, but also causes the formation of free radicals. Free radical species cause the 
oxidation of UHMWPE over time. Polyethylene oxidation degrades UHMWPE, and 
decreases its wear resistance. 
Several production techniques have been developed to reduce the generation of free 
radicals, including annealing and melting. Melting reduces free radical concentration more 
than annealing but adversely affects the yield stress and fatigue resistance of the polymer. 
Annealing below melting point has a less adverse effect on the mechanical properties, but is 
less effective than melting at free radical removal. Sterilization in an oxygen-free 
environment also produces more cross-linking and reduces free radical production78. 
Irradiation in an inert gas and vacuum packing is also now routinely carried out to reduce 
pre-implantation oxidation, however this does not prevent oxidation occurring in vivo. Faris 
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et al compared the wear rates of UHMWPE produced using three combinations of 
polyethylene production and sterilization techniques79 and found the best wear rates were 
achieved in sterilization by radiation in an inert gas with molded polyethylene. Irradiation 
sterilization of ram extruded components in an inert gas and in air had 11% and 16% more 
wear respectively.  
Highly cross-linked polyethylene has exhibited reduced wear rates clinically in short-term 
studies80,81, and thus their potential role in reducing the incidence of osteolysis is promising. 
Further developments in polyethylene modification techniques are currently being explored 
to further reduce oxidization in-vivo and optimize the wear performance of UHMWPE 
without compromising its other mechanical properties, and include doping with anti-
oxidants such as vitamin E and cycling of annealing and irradiating. However, the 
macrophage response in osteolysis is influenced by the size, composition and number of 
wear particles82,83. Particle size and number vary with the extent of cross-linking within the 
material. Although cross-linking reduces the total amount of wear debris generated versus 
conventional UHMWPE, the particle size produced is smaller, and the number of particles is 
increased, which may enhance their osteolytic potential in-vivo. Also, whilst increased cross-
linking results in enhanced wear resistance there is a reduction in fatigue strength 
potentially leading to mechanical failure84. 
6.3 Alternate bearing couples 
Although metal on polyethylene bearings have most commonly been used in THA, there is 
a long history of use of other bearing couples, including metal on metal, ceramic on ceramic, 
and ceramic on polyethylene.  
Metal on metal bearings have reduced wear rates compared with metal on polyethylene. 
Jacobbson reported a 77% 20-year survivorship of the metal on metal McKee Farrar THA 
compared to 73% for the Charnley THA85. Metal on metal prostheses also have the 
advantages of allowing a larger bearing diameter, improving stability characteristics, and 
are self-polishing. Although the volumetric wear rate of metal on metal bearings is low, the 
particles generated are in the nanometer range and the number of particles is far greater86. 
These particles circulate widely within the body and their systemic effects remain unclear. 
At a local level metal release can cause an adverse surrounding tissue reaction, termed 
aseptic lymphocytic vasculitis associated lesions (ALVAL), and inflammatory masses87,88. 
Metal hypersensitivity may also occur87. 
Ceramic on polyethylene and ceramic on ceramic bearing couples have lower wear  and 
osteolysis rates versus metal on polyethylene bearings in some long-term studies89,90. Most 
ceramic wear particles are also in the nanometer range and wear volume is lower than that 
of metal on metal bearing couples. A prospective randomized multicenter study of 930 hips 
comparing alumina-on-alumina with cobalt chromium-on-polyethylene bearing couples 
reported an alumina-alumina survival rate of 96.8% at 10 years91. However, cases of 
osteolysis have also been reported in poorly functioning ceramic on ceramic prostheses. 
Yoon reported osteolysis rates of 22% in a series of patients with ceramic on ceramic 
prostheses92. Nam reported a case of alumina debris induced pelvic and femoral osteolysis 
in a well-functioning prosthesis93. Ceramics are also expensive, have a small fracture risk 
due to their brittleness, and are sensitive to component mal-positioning that may result in 
impingement damage and stripe wear. There are also some reports of squeaking associated 
with ceramic on ceramic bearing couples94. 
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7. Surgical risk factors 
Regardless of prosthesis design and bearing surface, surgical technique is an important 
factor that affects prosthesis survival. Data from large national joint registries has recently 
facilitated examination of these factors in relation to prosthesis survival. 
7.1 Hospital type and surgeon operating volume 
Type of hospital and the surgeon undertaking the procedure can influence THA survival. 
Fowles et al showed that low operating volume is associated with increased risk of THA 
revision95. Similarly, Espehaug et al, using data from the Norwegian arthroplasty register, 
found the lowest revision rates amongst surgeons with the highest THA volume96. In the 
same study, university hospitals had higher revision rates than local and central hospitals. 
This may be attributed to the lower number of operations per surgeon at these hospitals or 
possible centralization of high-risk patients and more complex cases. Bordini et al found that 
prosthesis survival was negatively associated with lower surgeon skill38. 
7.2 Prosthesis alignment and soft tissue balancing 
Malalignment of prostheses may alter the articulation of prosthesis components with the 
potential to increase contact stresses and increase wear, this increases the incidence of edge 
loading and results in stripe wear in hard on hard bearing couples. Despite the advantage of 
larger femoral head size, soft tissue balancing remains important in the reduction of 
dislocation of the femoral head. Subluxation of the femoral head during the swing phase of 
gait, especially in metal on polyethylene couples, causes socket edge contact resulting in 
wear97. Complete dislocation of the femoral head may damage the head during dislocation-
relocation, and can increase wear rates.  
7.3 Prosthesis dislocation and interface micromotion 
Prosthesis stability influences the development of aseptic loosening. Motion between the 
prosthesis and bone contributes to the formation of a fibrous membrane rather than bone98. 
Bechtold et al found that particulate wear debris prevents bone formation in the presence of 
prosthesis instability 99. In addition, prosthesis motion alters local joint fluid pressures and 
can transport particles along the periprosthetic space. 
7.4 Cementing techniques 
Improvements in prosthesis survival have accompanied advances in cementation 
technique100. First generation cementing techniques involved finger packing of the cement 
without bone preparation, pressurization or use of a medullary plug. In the mid-seventies 
second generation techniques were adopted which involved improved canal preparation by 
pulsatile lavage that increased cement penetration and interdigitation, retrograde insertion 
of cement using a gun to reduce blood lamination, and the use of an intramedullary plug to 
limit the size of the cement column. Studies with 10 year follow up have shown that 2nd 
generation techniques were associated with a reduced the incidence in femoral loosening 
with rates of 3 to 7%101,102  compared with rates of approximately 30% at 10 years in first 
generation reports103,104. Third generation techniques included vacuum mixing of cement to 
reduce cement porosity and increase fatigue strength105, and cement pressurization to 
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further improve cement interdigitation. Subsequently 4th generation cementation techniques 
have added distal and proximal prosthesis centralizers to improve the stem position 
allowing for an optimal and even cement mantle. Herbert, in a review of the Swedish THA 
Register examining 160,000 cases, reported that the evolution from 1st to 3rd generation 
cementing techniques over a 20 year period was associated with a reduced incidence of 
revision for aseptic loosening100. 
8. Summary and future directions 
Aseptic loosening is the end result of a complex interaction of variables leading to 
development of osteolysis. Although the last 30 years has seen many advances in the 
understanding of these factors, osteolysis will remain a problem for the foreseeable future. 
Newer bearing surfaces have shown potential in wear rate reduction. However, wear particles 
from all materials have the potential to trigger an inflammatory response. The local and 
systemic consequences of metal release also need to be more clearly defined and quantitated. 
Further studies looking at prosthesis bone anchorage in conjuction with particle and pressure 
effects need to be explored, and the factors that influence loosening membrane formation.  
Currently the only effective treatment for aseptic loosening is revision surgery. Future 
advances in our understanding of the biological response to wear particles may lead to the 
development of biological markers for better prediction and early detection of osteolysis, 
and the development of non-surgical solutions for prophylaxis and therapy. Advances in 
genomic and bioinformatics technology have provided us with the opportunity to identify 
investigational targets for prophylaxis or treatment. Pharmocological and biological agents 
used in the treatment of osteolysis in metastatic disease and metabolic bone disease may 
have potential in osteolysis following THA. 
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